ArticleAnti-cancer drugs2025

The impact of bevacizumab intraperitoneal perfusion combined with paclitaxel and platinum-based chemotherapy on serum stromal-derived factor-1α (SDF-1α) and chemokine ligand 5 (CXCL-5) levels in patients with ovarian cancer after tumor cell debulking surgery.

Liangliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.